Reinforced erythroid differentiation inhibits leukemogenic potential of t(8;21) leukemia-Reference-Cited by-同舟云学术

Reinforced erythroid differentiation inhibits leukemogenic potential of t(8;21) leukemia

Published:2022-09-20 Issue:10 Volume:36 Page:
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:The FASEB Journal

Author:

Wang Meng‐Xi¹^ORCID,Yan Li²,Chen Juan¹,Zhao Jun‐Mei²,Zhu Jiang¹³⁴,Yu Shan‐He¹^ORCID

Affiliation:

1. Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai China

2. Department of Hematology Renmin Hospital of Wuhan University Wuhan China

3. School of Life Sciences and Biotechnology Shanghai Jiao‐Tong University Shanghai China

4. Collaborative Innovation Center of Hematology Ruijin Hospital Affiliated to Shanghai Jiao‐Tong University School of Medicine Shanghai China

Funder

National Key Research and Development Program of China

National Natural Science Foundation of China

Samuel Waxman Cancer Research Foundation

Shanghai Rising-Star Program

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.202200026RR

Reference50 articles.

1. Impact of chromosomal rearrangement upon DNA methylation patterns in leukemia

2. Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data

3. Targeted therapy for fusion-driven high-risk acute leukemia

4. MLL Leukemia and Future Treatment Strategies

5. A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia